| Xcovery's distinguished SAB combines leading biological, medicinal chemistry and clinical expertise in addition to drug development experience.
|
|
| Dr. Sydney Brenner |
|
| » |
Nobel Laureate (Medicine, 2002) |
| » |
President and Director of Science, The Molecular Sciences Institute, La Jolla and Berkeley 2000
|
| » |
Distinguished Research Professor, The Salk Institute, La Jolla, USA
|
|
|
| Professor Sir Philip Cohen FRS FRSE
|
|
| » |
Royal Society Research Professor, and Director, University of Dundee, Scotland School of Life Sciences Research Biocentre.
|
| » |
Director, Medical Research Council (MRC) Protein Phosphrylation Unit (PPU).
|
| » |
Director, Wellcome Trust Biocentre
|
| » |
The second most-cited scientist in the field of Biology & Biochemistry, and serine/threonine signaling expert.
|
|
|
| Dr. Brian Druker |
|
| » |
National Academy of Science |
| » |
Co-inventor and co-developer of Gleevec, Novartis' targeted small molecule therapeutic for multiple cancers, including CML and GIST. |
| » |
HHMI investigator and JELD-WEN Chair of Leukemia Research and Professor of Medicine, Oregon Health & Science University
|
| » |
Tyrosine kinase signaling expert.
|
|
|
| |
|